COPD pp 179-187 | Cite as

Imaging Heterogeneity of COPD

  • Sang Min LeeEmail author
  • Joon Beom Seo


Heterogeneity of chronic obstructive pulmonary disease (COPD) has been well recognized while our understanding of this agonizing disease has grown over the past two decades. As a result, the concept of COPD has been changed from an airflow limitation-centric view to a complex and heterogeneous condition. FEV1 by itself, which is representing airflow limitation, is no longer primarily used for assessing the complexity of COPD. In this context, imaging features, especially quantitative analysis of CT, have garnered attention as they have been demonstrated to be of help in evaluating patients’ status as well as predicting acute exacerbation and prognosis of patients. In this chapter, we reviewed previous research on imaging in COPD patients briefly and addressed the current concept and future direction of imaging phenotyping.


  1. 1.
    Global initiative for chronic obstructive pulmonary disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2015. Available via
  2. 2.
    Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183(9):1129–37. doi: 10.1164/rccm.201009-1414PP.CrossRefPubMedGoogle Scholar
  3. 3.
    Galban CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–5. doi: 10.1038/nm.2971.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Kim EY, Seo JB, Lee HJ, Kim N, Lee E, Lee SM, et al. Detailed analysis of the density change on chest CT of COPD using non-rigid registration of inspiration/expiration CT scans. Eur Radiol. 2015;25(2):541–9. doi: 10.1007/s00330-014-3418-0.CrossRefPubMedGoogle Scholar
  5. 5.
    Nakano Y, Muller NL, King GG, Niimi A, Kalloger SE, Mishima M, et al. Quantitative assessment of airway remodeling using high-resolution CT. Chest. 2002;122(6 Suppl):271S–5S.CrossRefGoogle Scholar
  6. 6.
    Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1102–8. doi: 10.1164/ajrccm.162.3.9907120.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Park TS, Lee JS, Seo JB, Hong Y, Yoo JW, Kang BJ, et al. Study design and outcomes of Korean obstructive lung disease (KOLD) cohort study. Tuberc Respir Dis. 2014;76(4):169–74. doi: 10.4046/trd.2014.76.4.169.CrossRefGoogle Scholar
  8. 8.
    Lynch DA, Austin JH, Hogg JC, Grenier PA, Kauczor HU, Bankier AA, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner society. Radiology. 2015;277(1):192–205. doi: 10.1148/radiol.2015141579.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kitaguchi Y, Fujimoto K, Kubo K, Honda T. Characteristics of COPD phenotypes classified according to the findings of HRCT. Respir Med. 2006;100(10):1742–52. doi: 10.1016/j.rmed.2006.02.003.CrossRefPubMedGoogle Scholar
  10. 10.
    Lee JH, Lee YK, Kim EK, Kim TH, Huh JW, Kim WJ, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2010;104(4):542–9. doi: 10.1016/j.rmed.2009.10.024.CrossRefPubMedGoogle Scholar
  11. 11.
    Gunen H, Hacievliyagil SS, Kosar F, Mutlu LC, Gulbas G, Pehlivan E, et al. Factors affecting survival of hospitalised patients with COPD. Eur Respir J. 2005;26(2):234–41. doi: 10.1183/09031936.05.00024804.CrossRefPubMedGoogle Scholar
  12. 12.
    Wilkinson TM, Donaldson GC, Hurst JR, Seemungal TA, Wedzicha JA. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–303. doi: 10.1164/rccm.200310-1443OC.CrossRefPubMedGoogle Scholar
  13. 13.
    Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261(1):274–82. doi: 10.1148/radiol.11110173.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–53. doi: 10.1056/NEJMoa032158.CrossRefPubMedGoogle Scholar
  15. 15.
    McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–75. doi: 10.1056/NEJMoa1106955.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Chae EJ, Seo JB, Song JW, Kim N, Park BW, Lee YK, et al. Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. AJR Am J Roentgenol. 2010;194(3):W248–55. doi: 10.2214/AJR.09.2672.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Parr DG, Stoel BC, Stolk J, Stockley RA. Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med. 2004;170(11):1172–8. doi: 10.1164/rccm.200406-761OC.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–73. doi: 10.1056/NEJMoa030287.CrossRefPubMedGoogle Scholar
  19. 19.
    Sciurba FC, Ernst A, Herth FJ, Strange C, Criner GJ, Marquette CH, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–44. doi: 10.1056/NEJMoa0900928.CrossRefPubMedGoogle Scholar
  20. 20.
    Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, et al. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(1):44–52. doi: 10.1164/rccm.201106-0992OC.CrossRefPubMedGoogle Scholar
  21. 21.
    Johannessen A, Skorge TD, Bottai M, Grydeland TB, Nilsen RM, Coxson H, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013;187(6):602–8. doi: 10.1164/rccm.201209-1722OC.CrossRefPubMedGoogle Scholar
  22. 22.
    Lutchmedial SM, Creed WG, Moore AJ, Walsh RR, Gentchos GE, Kaminsky DA. How common is airflow limitation in patients with emphysema on CT scan of the chest? Chest. 2015;148(1):176–84. doi: 10.1378/chest.14-1556.CrossRefPubMedGoogle Scholar
  23. 23.
    Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32(5):1371–85. doi: 10.1183/09031936.00015608.CrossRefPubMedGoogle Scholar
  24. 24.
    Matsuoka S, Washko GR, Yamashiro T, Estepar RS, Diaz A, Silverman EK, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med. 2010;181(3):218–25. doi: 10.1164/rccm.200908-1189OC.CrossRefPubMedGoogle Scholar
  25. 25.
    Estepar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, et al. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188(2):231–9. doi: 10.1164/rccm.201301-0162OC.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci U S A. 2010;107(16):7485–90. doi: 10.1073/pnas.0913880107.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Kohler D, Fischer J, Raschke F, Schonhofer B. Usefulness of GOLD classification of COPD severity. Thorax. 2003;58(9):825.CrossRefGoogle Scholar
  28. 28.
    Arne M, Lisspers K, Stallberg B, Boman G, Hedenstrom H, Janson C, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med. 2010;104(4):550–6. doi: 10.1016/j.rmed.2009.10.023.CrossRefPubMedGoogle Scholar
  29. 29.
    Zielinski J, Bednarek M, Gorecka D, Viegi G, Hurd SS, Fukuchi Y, et al. Increasing COPD awareness. Eur Respir J. 2006;27(4):833–52. doi: 10.1183/09031936.06.00025905.CrossRefPubMedGoogle Scholar
  30. 30.
    Wan ES, Hokanson JE, Murphy JR, Regan EA, Make BJ, Lynch DA, et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med. 2011;184(1):57–63. doi: 10.1164/rccm.201101-0021OC.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Kim SS, Yagihashi K, Stinson DS, Zach JA, McKenzie AS, Curran-Everett D, et al. Visual assessment of CT findings in smokers with nonobstructed spirometric abnormalities in the COPDGene Study. Chronic Obstr Pulm Dis (Miami). 2014;1(1):88–96. doi: 10.15326/jcopdf.1.1.2013.0001#sthash.L0atdpjM.dpuf.CrossRefGoogle Scholar
  32. 32.
    Soriano JB, Davis KJ, Coleman B, Visick G, Mannino D, Pride NB. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. Chest. 2003;124(2):474–81.CrossRefGoogle Scholar
  33. 33.
    de Marco R, Pesce G, Marcon A, Accordini S, Antonicelli L, Bugiani M, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population. PLoS One. 2013;8(5):e62985. doi: 10.1371/journal.pone.0062985.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest. 2005;128(4):2099–107. doi: 10.1378/chest.128.4.2099.CrossRefPubMedGoogle Scholar
  35. 35.
    Hardin M, Silverman EK, Barr RG, Hansel NN, Schroeder JD, Make BJ, et al. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127. doi: 10.1186/1465-9921-12-127.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Hardin M, Cho M, McDonald ML, Beaty T, Ramsdell J, Bhatt S, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014;44(2):341–50. doi: 10.1183/09031936.00216013.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Kim MA, Noh CS, Chang YJ, Hong YK, Lee JS, Lee SW, et al. Asthma and COPD overlap syndrome is associated with increased risk of hospitalisation. Int J Tuberc Lung Dis. 2015;19(7):864–9. doi: 10.5588/ijtld.14.0327.CrossRefPubMedGoogle Scholar
  38. 38.
    Cottin V, Cordier JF. The syndrome of combined pulmonary fibrosis and emphysema. Chest. 2009;136(1):1–2. doi: 10.1378/chest.09-0538.CrossRefPubMedGoogle Scholar
  39. 39.
    Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J. 2005;26(4):586–93. doi: 10.1183/09031936.05.00021005.CrossRefPubMedGoogle Scholar
  40. 40.
    Chae KJ, Jin GY, Han YM, Kim YS, Chon SB, Lee YS, et al. Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: a case-control study. Eur Radiol. 2015;25(8):2326–34. doi: 10.1007/s00330-015-3617-3.CrossRefPubMedGoogle Scholar
  41. 41.
    Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest. 2013;144(1):234–40. doi: 10.1378/chest.12-2403.CrossRefPubMedGoogle Scholar
  42. 42.
    Mejia M, Carrillo G, Rojas-Serrano J, Estrada A, Suarez T, Alonso D, et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest. 2009;136(1):10–5. doi: 10.1378/chest.08-2306.CrossRefPubMedGoogle Scholar
  43. 43.
    Kurashima K, Takayanagi N, Tsuchiya N, Kanauchi T, Ueda M, Hoshi T, et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology. 2010;15(5):843–8. doi: 10.1111/j.1440-1843.2010.01778.x.CrossRefPubMedGoogle Scholar
  44. 44.
    Ito I, Nagai S, Handa T, Muro S, Hirai T, Tsukino M, et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med. 2005;172(11):1378–82. doi: 10.1164/rccm.200506-953OC.CrossRefPubMedGoogle Scholar
  45. 45.
    Sakao S, Tatsumi K, Igari H, Watanabe R, Shino Y, Shirasawa H, et al. Association of tumor necrosis factor-alpha gene promoter polymorphism with low attenuation areas on high-resolution CT in patients with COPD. Chest. 2002;122(2):416–20.CrossRefGoogle Scholar
  46. 46.
    DeMeo DL, Hersh CP, Hoffman EA, Litonjua AA, Lazarus R, Sparrow D, et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med. 2007;176(1):42–8. doi: 10.1164/rccm.200612-1797OC.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, et al. Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(8):948–57. doi: 10.1164/rccm.201302-0247OC.CrossRefPubMedGoogle Scholar
  48. 48.
    Bowler RP, Jacobson S, Cruickshank C, Hughes GJ, Siska C, Ory DS, et al. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. Am J Respir Crit Care Med. 2015;191(3):275–84. doi: 10.1164/rccm.201410-1771OC.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Kim WJ, Oh YM, Sung J, Lee YK, Seo JB, Kim N, et al. CT scanning-based phenotypes vary with ADRB2 polymorphisms in chronic obstructive pulmonary disease. Respir Med. 2009;103(1):98–103. doi: 10.1016/j.rmed.2008.07.025.CrossRefPubMedGoogle Scholar
  50. 50.
    Kim WJ, Hoffman E, Reilly J, Hersh C, Demeo D, Washko G, et al. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J. 2011;37(1):39–43. doi: 10.1183/09031936.00173009.CrossRefPubMedGoogle Scholar
  51. 51.
    Dijkstra AE, Postma DS, van Ginneken B, Wielputz MO, Schmidt M, Becker N, et al. Novel genes for airway wall thickness identified with combined genome-wide association and expression analyses. Am J Respir Crit Care Med. 2015;191(5):547–56. doi: 10.1164/rccm.201405-0840OC.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Division of Cardiothoracic Radiology, Department of RadiologyAsan Medical Center, University of Ulsan College of MedicineSeoulSouth Korea

Personalised recommendations